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I GROWTH AND GROWTH HORMONE I N CHILDREN AFTER ALLOGENEIC ' BONE MARROW TRANSPLANTATION.
A l l children surviving bone marrow transplantation (BMT) 1980-84 1 have been followed every year regarding t h e i r growth. There are 21 long time survivors ape 1-14 a t the time of BMT. 3 had severe I a p l a s t i c anemia (SAA), 18 had leukemia. A l l patients were conditioned with cyklophosphamide, leukemic children also had 10 GY of t o t a l body i r r a d i a t i o n (TBI) delivered by a l i n e a r accelerator a t a mean dose r a t e <0,05 GYImin.
The children who suffered from SAA have a l l grown normally a f t e r I
BMT. The remaining 18 show a poor growth during the f i r s t year a f t e r BMT, 7/18 deviated -1 SD or more. Growth hormone (GH) stimul a t i o n t e s t s with insulin and arginine were performed every year. I Though growth was poor the f i r s t year, 19/20 had a normal GH response. A t year t h r e e , however, 10/18 f a i l e d t o respond normally.
'
To further investigate physiological GH secretion, 24 hour profiled were done in 13 cases. In 5 of these, t h e r e was not one significan GH-peak (>8 u g / l ) . 4 children had one peak and 4 children had 3-5 peaks. Also when calculating the area over baseline, 7/10 had ob-1 vious pathological p r o f i l e s . So f a r . 6 children had injection the-I rapy of GH f o r more than 6 months, 4 show increment of growth vela] c i t y .
-. ydig c e l l insufficiency i s a frequent canplication of l a t e r a l TI with 24 gy (NEJM 1983). To describe the long term llow-up and the testosterone (T) deficiency we studied, with i n t e r v a l time s i n c e TI >2yrs, 28 boys i r r a d i a t e d with 12X2Gy 4.8 t o 16.9 yrs, before (24) o r during (4) puberty. A l l but 4 ceived a l s o c r a n i a l prophylactic i r r a d i a t i o n . A l l but the 2 d e r s a t TI had leydig c e l l insufficiency manifested by a low T sponse t o hCG (7X1500U) and/or by increased basal plasma LH 5mIUIml) when bone age (BA) >12yrs (n=21). The 8 p a t i e n t s with ml (2) o r compensated (6) T secretion had n o m l spontaneous i r i l i s a t i o n with T between 4.3 and 8 nglml. This group included 11 the boys i r r a d i a t e d during puberty. Age a t TI and TIhCG were ighly correlated (n=21, ~4 . 6 2 , p(0.001). I n 6 cases, a 2nd KG e s t performed a t i n t e r v a l s from 0.6 t o 5.5yrs, showed a esponse i d e n t i c a l t o the 1st t e s t (r=0.99). Similarly i n 8 s e s having a 2nd evaluation a f t e r >2yrs, when BA>12yrs and I >5mIU/ml, a c o r r e l a t i o n was found between basal T and , epubertal T response t o hCG (r=0.79, ~(0.01).
conclusion 1 ) The s e v e r i t y of leydig c e l l insufficiency i s ( ghly r e l a t e d t o age a t t e s t i c u l a r i r r a d i a t i o n . 2) No signi-! cant change from t h e i n i t i a l evaluation was observed on , ollow-up. 3) Spontaneous pubertal v i r i l i s a t i o n may occur and a s usually permitted by compensated T insufficiency. 
ICHTHYOSIS( I ) AND HYPOGONADISM(H) IN T W O BROTHERS WITH DELETION OF THE SHORT ARM OF THE X-CHROMOSOME.
Two brothers aged 9.5(N) and 17 years(J) respectively, underwent b i l a t e r a l orcheopexy a t the age of 4 years and were recently exa mined for H. They were healthy,tall ,of normal intelligence and they presented skin lesions of I. The t e s t e s were small (lml in N b i l a t e r a l l y , and in $1 R:lml, L:3-4ml). J. had receive testosterone f o r 1 year and had Tanner I11 oubic hair. There was no response of serum testosterone t o HCG and no appreciable response of LH and FSH t o IV LHRH. Serum DHEAS values were 518 in N and 3700ng/ml in J . STS a c t i v i t y i n WBC was 0 pmols/hr/mo protein in both subjects (control:24.9). Flow cytometry showed the X chromosome t o be 2-3% smaller than normal, indicating a large deletion of about 5 million base pairs. No hybridization t o the probe GMGX9 (DXS 237) was found, indicating steroid s u l f a t a s e (STS) qene deletion. There was hybridization t o the probe d i c 56 (DXS 143). which i s proximal t o STS. This puts a proximal l i m i t on the extent of the deletion. They were heterozygous f o r the probe p19b a t the MIC2X locus which puts a d i s t a l l i m i t on the deletion. Hence, in these two brothers with I and H , a large deletion of the short arm of the X chromosome was disclosed which included the STS locus, the closely linked locus DXS 237 and the gene f o r hypoaonadism, findings which o f f e r the opportunity f o r speculations on the locus of control of normal t e s t i c u l a r development and function.
V. H e a s e , G. ~i s c h e r -D e p a r t m e n t o f Y a e d i a t r i c s , U n i v e r s i t y o f I 8 ; e E i A % o N s OF HcG AnE As EFFECTIVE As l o INJECTIONS I N THE TREATMENT OF CRYPTORCHI-IIISM T r e a t m e n t o f c r y p t o r c h i d i s m w i t h GnRH p r e p a r a t i o n s has some d i s a d v a n t e g e s -i t r e q u i r e s d a i l y a p p l i c a t i o n s o v e r 4 w e e k s a n d i n v o l v e s t h e u n c e r t a i n t y o f p a r e n t s ' c o o p e r a t i o n . H C G t h e r a p y (i.m.)
is s a f e r b u t 1 0 i n j e ot i o n s a c c o r d i n g t o t h e IHP s c h e d u l e c a n n o l o n g e r b e a c c e p t e d . T h a t ' s why i n e n a l t e r n a t i v e s t u d y w h i c h inc l u d e d 3 0 9 b o s w i t h c r y p t o r c h i d i s m ( 1 5 8 u n i l a t e r a l . 151 b i l a t e r a l g , a HCG s c h e d u l e ( 1 ) w i t h 3 HCG i.m. inj e c t i o n s (1-3 yrs=3x10001U,3-6 y r s = 3 x 1 5 0 0 I U . 6-10 y r e = j x 3 0 0 0 I U , 10-1 3-3x5000IU; i n t e r v a l s s 7 -l O d e y s , n = 1 4 6 ) a n d t h e IHF s c h e d u l e ( 1 1 ) w i t h 10 i n j . i n ege-depend e n t d o s a g e s n = 1 4 6 ) w e r e compared. C o m p l e t e d e s c e n t t w a s s e e n i n 4 /I51 (30.52) t e s t e s ( a b d o m i n a l , i n g u in a l r e t e n t i o n e n d p r e e c r o t a l t e s t e s u n d e r I e n d 80/ 2 0 3 t e s t e s (39.4%) u n d e r I1 ( p n . 8 . j P a r t i a l d e s c e n t o c o u r e d i n 41% o f t h e c a s e s u n d e r I a n d 40.4% u n d e r 11. In p a t i e n t s w i t h a b d o m i n a l a n d i n g u i n a l r e t e n t i o n t h o p o s i t i v e r e e u l t e w e r e com a r a b l e i n t h e a g e g r o u p e 1-3 ( n u 1 2 4 ) a n d 3 -6 y r e ( n = l~l ? , b u t i n t h e a g e g r o u 6 -1 3 y r a (n-$33) 1 0 i n j . w e r e more e f f e c t i v e ( p 4 0.05P. F o l l o w -u p r e s u l t s 2-9 m o n t h s a f t e r t h e r a p y w e r e n e a rl y i d e n t i c a l l y . Concl.:HCGtherapy w i t h 3 HCG i n j e c t .
is a s a f e e l t e r n~r o o e d u r e t o t h e GnKH t h e r a p y . It is oeneved that the positive action of hCC on cryptorchidism is mediated by the rise in endogenous testosterone (T). Previous studies have shown that plasma T rises steadily for 4-5 days (d.) after a single hCC injection (inj.). This study was undertaken to test the hypothesis that it is unnecessary to repeat inj. before that peak. The proposed protocol (Rx) (1) consisted of 4 IM inj. of 100 IU/kg of hCG a t 4 (n = 16) or 5 d. intervals (n = 79). Results, being similar, are given in the total group (I) (n = 95) and compared to that of a previous Rx (11) using 7 inj. of 1500 IU of hCC every 48 h (group 11, n = 440). The % of unilateral (UC; 60%) and bilateral cryptorchidism (BC; 40%) was identical in both groups. Success (complete descent) was recorded in 50.9% of UC and 50% of BC in group I, and 40.7% of UC and 36.7% of RC in group 11. Rate of relapse (at 1-4 yrs) was similar in group 1 (9%) and 11 (10%). Plasma T was measured respectively 4 and I d. after the last inj. in Rx I and 11. Mean (+SD) T levels (ngldl) were not different whether Rx was successful or no< either with Rx I (392 + 207 and 430 + 207) or I1 (495 + 247 and 541 + 304). In total groups, T level:
were lower 6 = 0.003) w i t h x x l(410 + 2c7) than with Rx 11 (516 + 273), possibly due to a relatively late tirne of<ampling in Rx I. Finally, TTalues were normally distributed in Rx 1 but not in Rx I1 (median being respectively 384 and 443). In conclusion, a Rx using hCC a t doses related to body size and inj. a t only 4-5 day intervals appears as efficient, or even more, as Rx using frequent hCG injections in the treatment of undescended testis.
